Silence Therapeutics PLC ADR Annual stock financials by MarketWatch. View the latest SLN financial statements, income statements and financial ratios.

Buick is hardly the hottest brand in the U.S. market at the moment, with models like the Encore crossover lacking the unique features and driving dynamics to compete with the best in the segment. The ...

This collection of official Santa Clara University logos reflects the institution's identity, values, and traditions. They are essential to maintaining a consistent brand presence. Please use them ...

Access detailed historical stock prices, including daily closing prices, for SLN. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...

BMW Alpina has a new badge that retains the mechanical components seen on the original but ditches the red-and-blue shield. BMW purchased the German tuner in 2022 and is gearing up to relaunch the ...

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA ...

Steven Nickolas is a writer and has 10+ years of experience working as a consultant to retail and institutional investors. Charlene Rhinehart is a CPA , CFE, chair of an Illinois CPA Society committee ...

Imagine our campus as a place where all its members make an effort—in how they live, work, and study—to adopt and spread more sustainable habits. The Sustainability Liaisons Network (SLN) are cohorts ...

The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032, registering a CAGR of 7.47% during ...

Topline results for Phase 2 SANRECO trial of divesiran, a first-in-class siRNA for polycythemia vera (PV), on-track for third quarter of 2026 ...

The management of axillary lymph nodes in breast cancer is continually evolving. Recent data now support omitting axillary lymph node dissection (ALND) in most patients with metastases in up to two ...